Report cover image

Global Paroxetine Market Analysis and Forecast 2025-2031

Publisher APO Research, Inc.
Published Oct 20, 2025
Length 190 Pages
SKU # APRC20561972

Description

Summary

According to APO Research, The global Paroxetine market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Paroxetine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Paroxetine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Paroxetine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Paroxetine is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Paroxetine include Teva, Sun Pharmaceutical, Mylan, Aurobindo, Sebela Pharmaceuticals, Neurocon Inc, Lupin, Lifegenix and Lannett Company, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Paroxetine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020 - 2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Paroxetine, also provides the sales of main regions and countries. Of the upcoming market potential for Paroxetine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Paroxetine sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Paroxetine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Paroxetine sales, projected growth trends, production technology, application and end-user industry.

Paroxetine Segment by Company

Teva
Sun Pharmaceutical
Mylan
Aurobindo
Sebela Pharmaceuticals
Neurocon Inc
Lupin
Lifegenix
Lannett Company
Jubilant Pharma
Apotex
Paroxetine Segment by Type

Paroxetine Hydrochloride Drug
Paroxetine Mesylate Drug
Paroxetine Segment by Application

Depression
Social anxiety disorder
Panic disorder
Others
Paroxetine Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Paroxetine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Paroxetine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Paroxetine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Paroxetine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Paroxetine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Paroxetine sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Paroxetine Market by Type
1.2.1 Global Paroxetine Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 Paroxetine Hydrochloride Drug
1.2.3 Paroxetine Mesylate Drug
1.3 Paroxetine Market by Application
1.3.1 Global Paroxetine Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Depression
1.3.3 Social anxiety disorder
1.3.4 Panic disorder
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Goals and Objectives
2 Paroxetine Market Dynamics
2.1 Paroxetine Industry Trends
2.2 Paroxetine Industry Drivers
2.3 Paroxetine Industry Opportunities and Challenges
2.4 Paroxetine Industry Restraints
3 Global Market Growth Prospects
3.1 Global Paroxetine Revenue Estimates and Forecasts (2020-2031)
3.2 Global Paroxetine Revenue by Region
3.2.1 Global Paroxetine Revenue by Region: 2020 VS 2024 VS 2031
3.2.2 Global Paroxetine Revenue by Region (2020-2025)
3.2.3 Global Paroxetine Revenue by Region (2026-2031)
3.2.4 Global Paroxetine Revenue Market Share by Region (2020-2031)
3.3 Global Paroxetine Sales Estimates and Forecasts 2020-2031
3.4 Global Paroxetine Sales by Region
3.4.1 Global Paroxetine Sales by Region: 2020 VS 2024 VS 2031
3.4.2 Global Paroxetine Sales by Region (2020-2025)
3.4.3 Global Paroxetine Sales by Region (2026-2031)
3.4.4 Global Paroxetine Sales Market Share by Region (2020-2031)
3.5 US & Canada & Mexico
3.6 Europe
3.7 China
3.8 Asia (Excluding China)
3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
4.1 Global Paroxetine Revenue by Manufacturers
4.1.1 Global Paroxetine Revenue by Manufacturers (2020-2025)
4.1.2 Global Paroxetine Revenue Market Share by Manufacturers (2020-2025)
4.1.3 Global Paroxetine Manufacturers Revenue Share Top 10 and Top 5 in 2024
4.2 Global Paroxetine Sales by Manufacturers
4.2.1 Global Paroxetine Sales by Manufacturers (2020-2025)
4.2.2 Global Paroxetine Sales Market Share by Manufacturers (2020-2025)
4.2.3 Global Paroxetine Manufacturers Sales Share Top 10 and Top 5 in 2024
4.3 Global Paroxetine Sales Price by Manufacturers (2020-2025)
4.4 Global Paroxetine Key Manufacturers Ranking, 2023 VS 2024 VS 2025
4.5 Global Paroxetine Key Manufacturers Manufacturing Sites & Headquarters
4.6 Global Paroxetine Manufacturers, Product Type & Application
4.7 Global Paroxetine Manufacturers' Establishment Date
4.8 Market Competitive Analysis
4.8.1 Global Paroxetine Market CR5 and HHI
4.8.2 2024 Paroxetine Tier 1, Tier 2, and Tier 3
5 Paroxetine Market by Type
5.1 Global Paroxetine Revenue by Type
5.1.1 Global Paroxetine Revenue by Type (2020 VS 2024 VS 2031)
5.1.2 Global Paroxetine Revenue by Type (2020-2031) & (US$ Million)
5.1.3 Global Paroxetine Revenue Market Share by Type (2020-2031)
5.2 Global Paroxetine Sales by Type
5.2.1 Global Paroxetine Sales by Type (2020 VS 2024 VS 2031)
5.2.2 Global Paroxetine Sales by Type (2020-2031) & (k units)
5.2.3 Global Paroxetine Sales Market Share by Type (2020-2031)
5.3 Global Paroxetine Price by Type
6 Paroxetine Market by Application
6.1 Global Paroxetine Revenue by Application
6.1.1 Global Paroxetine Revenue by Application (2020 VS 2024 VS 2031)
6.1.2 Global Paroxetine Revenue by Application (2020-2031) & (US$ Million)
6.1.3 Global Paroxetine Revenue Market Share by Application (2020-2031)
6.2 Global Paroxetine Sales by Application
6.2.1 Global Paroxetine Sales by Application (2020 VS 2024 VS 2031)
6.2.2 Global Paroxetine Sales by Application (2020-2031) & (k units)
6.2.3 Global Paroxetine Sales Market Share by Application (2020-2031)
6.3 Global Paroxetine Price by Application
7 Company Profiles
7.1 Teva
7.1.1 Teva Comapny Information
7.1.2 Teva Business Overview
7.1.3 Teva Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.1.4 Teva Paroxetine Product Portfolio
7.1.5 Teva Recent Developments
7.2 Sun Pharmaceutical
7.2.1 Sun Pharmaceutical Comapny Information
7.2.2 Sun Pharmaceutical Business Overview
7.2.3 Sun Pharmaceutical Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.2.4 Sun Pharmaceutical Paroxetine Product Portfolio
7.2.5 Sun Pharmaceutical Recent Developments
7.3 Mylan
7.3.1 Mylan Comapny Information
7.3.2 Mylan Business Overview
7.3.3 Mylan Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.3.4 Mylan Paroxetine Product Portfolio
7.3.5 Mylan Recent Developments
7.4 Aurobindo
7.4.1 Aurobindo Comapny Information
7.4.2 Aurobindo Business Overview
7.4.3 Aurobindo Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.4.4 Aurobindo Paroxetine Product Portfolio
7.4.5 Aurobindo Recent Developments
7.5 Sebela Pharmaceuticals
7.5.1 Sebela Pharmaceuticals Comapny Information
7.5.2 Sebela Pharmaceuticals Business Overview
7.5.3 Sebela Pharmaceuticals Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.5.4 Sebela Pharmaceuticals Paroxetine Product Portfolio
7.5.5 Sebela Pharmaceuticals Recent Developments
7.6 Neurocon Inc
7.6.1 Neurocon Inc Comapny Information
7.6.2 Neurocon Inc Business Overview
7.6.3 Neurocon Inc Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.6.4 Neurocon Inc Paroxetine Product Portfolio
7.6.5 Neurocon Inc Recent Developments
7.7 Lupin
7.7.1 Lupin Comapny Information
7.7.2 Lupin Business Overview
7.7.3 Lupin Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.7.4 Lupin Paroxetine Product Portfolio
7.7.5 Lupin Recent Developments
7.8 Lifegenix
7.8.1 Lifegenix Comapny Information
7.8.2 Lifegenix Business Overview
7.8.3 Lifegenix Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.8.4 Lifegenix Paroxetine Product Portfolio
7.8.5 Lifegenix Recent Developments
7.9 Lannett Company
7.9.1 Lannett Company Comapny Information
7.9.2 Lannett Company Business Overview
7.9.3 Lannett Company Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.9.4 Lannett Company Paroxetine Product Portfolio
7.9.5 Lannett Company Recent Developments
7.10 Jubilant Pharma
7.10.1 Jubilant Pharma Comapny Information
7.10.2 Jubilant Pharma Business Overview
7.10.3 Jubilant Pharma Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.10.4 Jubilant Pharma Paroxetine Product Portfolio
7.10.5 Jubilant Pharma Recent Developments
7.11 Apotex
7.11.1 Apotex Comapny Information
7.11.2 Apotex Business Overview
7.11.3 Apotex Paroxetine Sales, Revenue, Price and Gross Margin (2020-2025)
7.11.4 Apotex Paroxetine Product Portfolio
7.11.5 Apotex Recent Developments
8 North America
8.1 North America Paroxetine Market Size by Type
8.1.1 North America Paroxetine Revenue by Type (2020-2031)
8.1.2 North America Paroxetine Sales by Type (2020-2031)
8.1.3 North America Paroxetine Price by Type (2020-2031)
8.2 North America Paroxetine Market Size by Application
8.2.1 North America Paroxetine Revenue by Application (2020-2031)
8.2.2 North America Paroxetine Sales by Application (2020-2031)
8.2.3 North America Paroxetine Price by Application (2020-2031)
8.3 North America Paroxetine Market Size by Country
8.3.1 North America Paroxetine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
8.3.2 North America Paroxetine Sales by Country (2020 VS 2024 VS 2031)
8.3.3 North America Paroxetine Price by Country (2020-2031)
8.3.4 United States
8.3.5 Canada
8.3.6 Mexico
9 Europe
9.1 Europe Paroxetine Market Size by Type
9.1.1 Europe Paroxetine Revenue by Type (2020-2031)
9.1.2 Europe Paroxetine Sales by Type (2020-2031)
9.1.3 Europe Paroxetine Price by Type (2020-2031)
9.2 Europe Paroxetine Market Size by Application
9.2.1 Europe Paroxetine Revenue by Application (2020-2031)
9.2.2 Europe Paroxetine Sales by Application (2020-2031)
9.2.3 Europe Paroxetine Price by Application (2020-2031)
9.3 Europe Paroxetine Market Size by Country
9.3.1 Europe Paroxetine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
9.3.2 Europe Paroxetine Sales by Country (2020 VS 2024 VS 2031)
9.3.3 Europe Paroxetine Price by Country (2020-2031)
9.3.4 Germany
9.3.5 France
9.3.6 U.K.
9.3.7 Italy
9.3.8 Russia
9.3.9 Spain
9.3.10 Netherlands
10 China
10.1 China Paroxetine Market Size by Type
10.1.1 China Paroxetine Revenue by Type (2020-2031)
10.1.2 China Paroxetine Sales by Type (2020-2031)
10.1.3 China Paroxetine Price by Type (2020-2031)
10.2 China Paroxetine Market Size by Application
10.2.1 China Paroxetine Revenue by Application (2020-2031)
10.2.2 China Paroxetine Sales by Application (2020-2031)
10.2.3 China Paroxetine Price by Application (2020-2031)
11 Asia (Excluding China)
11.1 Asia Paroxetine Market Size by Type
11.1.1 Asia Paroxetine Revenue by Type (2020-2031)
11.1.2 Asia Paroxetine Sales by Type (2020-2031)
11.1.3 Asia Paroxetine Price by Type (2020-2031)
11.2 Asia Paroxetine Market Size by Application
11.2.1 Asia Paroxetine Revenue by Application (2020-2031)
11.2.2 Asia Paroxetine Sales by Application (2020-2031)
11.2.3 Asia Paroxetine Price by Application (2020-2031)
11.3 Asia Paroxetine Market Size by Country
11.3.1 Asia Paroxetine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
11.3.2 Asia Paroxetine Sales by Country (2020 VS 2024 VS 2031)
11.3.3 Asia Paroxetine Price by Country (2020-2031)
11.3.4 Japan
11.3.5 South Korea
11.3.6 India
11.3.7 Australia
11.3.8 Taiwan
11.3.9 Southeast Asia
12 South America, Middle East and Africa
12.1 SAMEA Paroxetine Market Size by Type
12.1.1 SAMEA Paroxetine Revenue by Type (2020-2031)
12.1.2 SAMEA Paroxetine Sales by Type (2020-2031)
12.1.3 SAMEA Paroxetine Price by Type (2020-2031)
12.2 SAMEA Paroxetine Market Size by Application
12.2.1 SAMEA Paroxetine Revenue by Application (2020-2031)
12.2.2 SAMEA Paroxetine Sales by Application (2020-2031)
12.2.3 SAMEA Paroxetine Price by Application (2020-2031)
12.3 SAMEA Paroxetine Market Size by Country
12.3.1 SAMEA Paroxetine Revenue Grow Rate by Country (2020 VS 2024 VS 2031)
12.3.2 SAMEA Paroxetine Sales by Country (2020 VS 2024 VS 2031)
12.3.3 SAMEA Paroxetine Price by Country (2020-2031)
12.3.4 Brazil
12.3.5 Argentina
12.3.6 Chile
12.3.7 Colombia
12.3.8 Peru
12.3.9 Saudi Arabia
12.3.10 Israel
12.3.11 UAE
12.3.12 Turkey
12.3.13 Iran
12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
13.1 Paroxetine Value Chain Analysis
13.1.1 Paroxetine Key Raw Materials
13.1.2 Raw Materials Key Suppliers
13.1.3 Manufacturing Cost Structure
13.1.4 Paroxetine Production Mode & Process
13.2 Paroxetine Sales Channels Analysis
13.2.1 Direct Comparison with Distribution Share
13.2.2 Paroxetine Distributors
13.2.3 Paroxetine Customers
14 Concluding Insights
15 Appendix
15.1 Reasons for Doing This Study
15.2 Research Methodology
15.3 Research Process
15.4 Authors List of This Report
15.5 Data Source
15.5.1 Secondary Sources
15.5.2 Primary Sources
15.6 Disclaimer
How Do Licenses Work?
Request A Sample
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.